🔗 Permalink

Inventor profile of:

Keith T. Demarest

City:

Flemington, New Jersey

Country:

United States

Published Applications:

Last publication date:

2017-10-12

Top Assignees for applications by Keith T. Demarest

The entities that hold a legal rights for patent applications filed by inventor Demarest Keith T.:

Janssen Pharmaceutica NV 7 Beerse, Belgium
Janssen Pharmaceutica, N.V. 4 , Belgium
Ortho-McNeil Pharmaceutical, Inc. 3 Raritan, NJ United States
Janssen Pharmaceuticals, NV 1 Beerse, Belgium
Ortho-Muniel Pharmaceutical, Inc. 1 Raritan, NJ United States

Recent patent applications by Demarest Keith T.

Keith T. Demarest from Flemington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-10-12

US20170290800A1

Human necessities

GPR40 agonists in anti-diabetic drug combinations

#2 | 2011-03-17

US20110065200A1

Physics

Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion

#3 | 2010-12-30

US20100331406A1

Chemistry; metallurgy

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

#4 | 2010-09-09

US20100227857A1

Chemistry; metallurgy

3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors

#5 | 2010-05-13

US20100120748A1

Chemistry; metallurgy

Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol

#6 | 2009-03-19

US20090075864A1

Human necessities

Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

#7 | 2008-04-24

US20080096802A1

Human necessities

Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators

#8 | 2008-03-27

US20080076754A1

Chemistry; metallurgy

Substituted spiroheterocycles

#9 | 2008-03-27

US20080076753A1

Chemistry; metallurgy

Substituted spiroheterocycles

#10 | 2007-11-15

US20070265304A1

Chemistry; metallurgy

1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors

#11 | 2007-11-15

US20070265252A1

Chemistry; metallurgy

3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors

#12 | 2007-10-18

US20070244094A1

Chemistry; metallurgy

Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol

#13 | 2007-09-20

US20070219245A1

Human necessities

METHOD OF USE FOR SUBSTITUTED DIPIPERIDINE CCR2 ANTAGONISTS

#14 | 2007-08-23

US20070197590A1

Chemistry; metallurgy

SUBSTITUTED DIPIPERIDINE CCR2 ANTAGONISTS

#15 | 2006-11-02

US20060247314A1

Chemistry; metallurgy

Substituted tetralins and indanes

#16 | 2006-07-13

US20060154949A1

Chemistry; metallurgy

Arylindenopyridines and related therapeutic and prophylactic methods

#17 | 2006-05-04

US20060094786A1

Chemistry; metallurgy

Treating syndrome X with substituted tetralins and indanes

#18 | 2006-04-06

US20060074130A1

Chemistry; metallurgy

Methods of using substituted tetralins and indanes

#19 | 2006-03-16

US20060058393A1

Chemistry; metallurgy

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

#20 | 2005-10-27

US20050239782A1

Human necessities

Arylindenopyridines and related therapeutic and prophylactic methods

#21 | 2005-09-01

US20050191668A1

Chemistry; metallurgy

Methods of using peroxisome proliferator-activated receptor alpha target genes

#22 | 2005-06-07

US10259139

Arylindenopyridines and related therapeutic and prophylactic methods

#23 | 2005-01-04

US10115725

Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

InventorID:

2006974 ⎘